We are live on
!
Find out more
Acadia Pharmaceuticals
ACAD
ACAD
266 hedge funds and large institutions have $6.17B invested in Acadia Pharmaceuticals in 2020 Q3 according to their latest regulatory filings, with 53 funds opening new positions, 103 increasing their positions, 85 reducing their positions, and 81 closing their positions.
New
Increased
Maintained
Reduced
Closed
21% more repeat investments, than reductions
Existing positions increased: 103 | Existing positions reduced: 85
17% more funds holding in top 10
Funds holding in top 10: 6 → 7 (+1)
3.55% less ownership
Funds ownership: 98.03% → 94.48% (-3.5%)
10% less funds holding
Funds holding: 297 → 266 (-31)
17% less capital invested
Capital invested by funds: $7.4B → $6.17B (-$1.24B)
27% less call options, than puts
Call options by funds: $33M | Put options by funds: $45.2M
35% less first-time investments, than exits
New positions opened: 53 | Existing positions closed: 81
Holders
266
Holders Change
-31
Holders Change %
-10.44%
% of All Funds
5.37%
Holding in Top 10
7
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+16.67%
% of All Funds
0.14%
New
53
Increased
103
Reduced
85
Closed
81
Calls
$33M
Puts
$45.2M
Net Calls
-$12.2M
Net Calls Change
-$5.76M
Top Buyers
| 1 |
Janus Henderson Group
London,
United Kingdom
|
+$77.6M |
| 2 |
MWNA
Marshall Wace North America
New York
|
+$51.6M |
| 3 |
Marshall Wace
London,
United Kingdom
|
+$40.3M |
| 4 |
FAM
Fred Alger Management
New York
|
+$37.3M |
| 5 |
Thrivent Financial for Lutherans
Minneapolis,
Minnesota
|
+$33.5M |
Top Sellers
| 1 |
Citadel Advisors
Miami,
Florida
|
-$56M |
| 2 |
HM
HealthCor Management
New York
|
-$49.7M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$45M |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
-$41.1M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$34.7M |
